XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
The Guangzhou-based EV startup said that the company's deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday.
美国股市涨跌互现，道琼斯指数周一下跌超过100点。
Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Monday's session.
小鹏公司（纽约证券交易所代码：XPEV）的股价在周一的交易中大幅上涨。
The company delivered 30,895 vehicles last month, marking an increase of 54% year-over-year and 29% from October.
该公司上个月交付了30,895辆汽车，同比增长54％，比10月份增长29％。
The Guangzhou-based EV startup said that the company's deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.
这家总部位于广州的电动汽车初创公司表示，该公司仅小鹏Mona M03掀背轿跑车的交付量就连续第三个月超过1万辆。该公司上个月推出的小鹏P7+轿车的交付量也超过了7,000辆。
XPeng shares jumped 6.4% to $12.82 on Monday.
周一，小鹏股价上涨6.4％，至12.82美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易日其他一些上涨的大型股票。
- NovoCure Limited (NASDAQ:NVCR) shares gained 29.9% to $26.04 after the company announced its Phase 3 PANOVA-Trial met its primary endpoint and demonstrated a statistically significant improvement in its median overall survival rate.
- Super Micro Computer, Inc. (NASDAQ:SMCI) surged 22% to $39.83 after the company announced it completed a review by an independent special committee and stated EY's conclusions were not supported by findings.
- Fastly, Inc. (NYSE:FSLY) jumped 17% to $9.92.
- Nebius Group N.V. (NASDAQ:NBIS) shares gained 15.5% to $25.40 after the company announced it entered a $700 million private placement financing agreement with institutional investors.
- Enovix Corporation (NASDAQ:ENVX) gained 15.1% to $10.65.
- Zeta Global Holdings Corp. (NYSE:ZETA) jumped 14.6% to $24.41.
- PTC Therapeutics, Inc. (NASDAQ:PTCT) surged 14.3% to $50.15 after the company announced it signed a global licensee and collaboration agreement with Novartis for its PTC518 Huntington's Disease program.
- Dana Incorporated (NYSE:DAN) gained 14% to $11.39 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $18.
- MINISO Group Holding Limited (NYSE:MNSO) gained 12.9% to $22.60. The company, on Friday, posted first-quarter results.
- Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) climbed 11.3% to $7.87.
- Akso Health Group (NASDAQ:AHG) rose 8.8% to $0.9000.
- Abercrombie & Fitch Co. (NYSE:ANF) gained 8.2% to $161.94.
- Merus N.V. (NASDAQ:MRUS) gained 8% to $48.43 after the company announced it entered into an agreement to exclusively license the right to Ptx the right to commercialize Zenocutuzumab (Zeno) for Nrg1 Fusion-positive cancer in the US.
- The Gap, Inc. (NYSE:GAP) rose 5.7% to $25.63 after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $28 to $30.
- NovoCure Limited（纳斯达克股票代码：NVCR）股价上涨29.9％，至26.04美元，此前该公司宣布其第三阶段Panova试验已达到其主要终点，总体存活率中位数有了统计学上的显著改善。
- 超级微电脑公司（纳斯达克股票代码：SMCI）上涨22％，至39.83美元，此前该公司宣布已完成独立特别委员会的审查，并表示安永的结论没有得到调查结果的支持。
- Fastly, Inc.（纽约证券交易所代码：FSLY）上涨17％，至9.92美元。
- Nebius Group N.V.（纳斯达克股票代码：NBIS）股价上涨15.5％，至25.40美元，此前该公司宣布与机构投资者签订了7亿美元的私募融资协议。
- Enovix公司（纳斯达克股票代码：ENVX）上涨15.1％，至10.65美元。
- 泽塔环球控股公司（纽约证券交易所代码：ZETA）上涨14.6％，至24.41美元。
- PTC Therapeutics, Inc.（纳斯达克股票代码：PTCT）上涨14.3％，至50.15美元，此前该公司宣布与诺华签署了其 PTC518 亨廷顿氏病计划的全球被许可人和合作协议。
- 达纳公司（纽约证券交易所代码：DAN）上涨14％，至11.39美元，此前巴克莱将该股从等权重上调至增持，并将目标股价从12美元上调至18美元。
- 名创集团控股有限公司（纽约证券交易所代码：MNSO）上涨12.9％，至22.60美元。该公司周五公布了第一季度业绩。
- Recursion Pharmicals, Inc.（纳斯达克股票代码：RXRX）上涨11.3％，至7.87美元。
- Akso Health Group（纳斯达克股票代码：AHG）上涨8.8％，至0.9000美元。
- Abercrombie & Fitch Co.纽约证券交易所代码：ANF）上涨8.2％，至161.94美元。
- Merus N.V.（纳斯达克股票代码：MRUS）上涨8％，至48.43美元，此前该公司宣布达成协议，独家许可Ptx在美国将Zenocutuzumab（Zeno）商业化用于治疗Nrg1 Fusion阳性癌症的权利。
- Gap, Inc.（纽约证券交易所代码：GAP）上涨5.7％，至25.63美元，此前摩根大通将该股从中性上调至增持，并将目标股价从28美元上调至30美元。
Now Read This:
现在阅读这篇文章：
- Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields
- 华尔街最准确的分析师对3只提供高股息收益率的金融股票发表了看法
